Endometrial response to concurrent treatment with vaginal progesterone and transdermal estradiol

Climacteric

Volumn 15, Issue 5, 2012, Pages 455-459

  Fernandez Murga L ^a   Hermenegildo, C ^b   Tarin J J ^c   Garcia Perez M A ^b   Cano, A ^c,d  

^a Development and Application of Composite Materials   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

amenorrhea; endometrium; intermittent administration; Transdermal estradiol; vaginal progesterone

Indexed keywords

ESTRADIOL; PROGESTERONE;

ADULT; AMENORRHEA; ARTICLE; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OPEN STUDY; PRIORITY JOURNAL; SPOTTING; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; VAGINA BLEEDING;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRAVAGINAL; ATROPHY; BIOPSY; ENDOMETRIUM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE; UTERINE HEMORRHAGE;

EID: 84866376226     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2011.644360     Document Type: Article

References (20)

1. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefi ts of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33
2. Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997;3:159-71 (Pubitemid 27389987)
3. Casper RF, Chapdelaine A. Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy. Am J Obstet Gynecol 1993;168:1188-94
4. Kroft J, Klostermann NR, Moody JR, et al. A novel regimen of combination transdermal estrogen and intermittent vaginally administered progesterone for relief of menopausal symptoms. Gynecol Endocrinol 2010;26:902-8
5. Cano A, Tarín JJ, Dueñas JL. Two-year prospective, randomized trial comparing an innovative twice-a-week progestin regimen with a continuous combined regimen as postmenopausal hormone therapy. Fertil Steril 1999;71:129-36 (Pubitemid 29042356)
6. The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1996;275:370-5
7. Fournier A, Berrino F, Clavel-Chapelon F Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat 2008;107:103-11
8. L'hermite M, Simoncini T, Fuller S, et al. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review. Maturitas 2008;60:185-201
9. Cicinelli E. Intravaginal oestrogen and progestin administration: advantages and disadvantages. Best Pract Res Clin Obstet Gynaecol 2008;22:391-405 (Pubitemid 351292331)
10. Birkhäuser MH, Reinecke I. Current trends in hormone replacement therapy: perceptions and usage. Climacteric 2008;11:192-200
11. Kurman RJ, Norris HJ. Endometrial hyperplasia and related cellular changes. In Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract, 4th edn. New York, NY: Springer Verlag, 1994:411-37
12. Sitruk-Ware R. Pharmacological profi le of progestins. Maturitas 2008;61:151-7
13. Hermsmeyer RK, Thompson TL, Pohost GM, et al. Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity? Nat Clin Pract Cardiovasc Med 2008;5:387-95 (Pubitemid 351935572)
14. Bakken K, Fournier A, Lund E, et al. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2011;128:144-56
15. Moyer DL, de Lignieres B, Driguez P, et al. Prevention of endome-trial hyperplasia by progesterone during long-term estradiol replacement: infl uence of bleeding pattern and secretory changes. Fertil Steril 1993;59:992-7 (Pubitemid 23139667)
16. Archer DF, Dorin M, Lewis V, Schneider DL, et al. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding. Fertil Steril 2001;75:1080-7 (Pubitemid 32522601)
17. Jacobs I, Gentry-Maharaj A, Burnell M, et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmen-opausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol 2011;12:38-48
18. Cano A. Compliance to hormone replacement therapy in meno-pausal women controlled in a third level academic centre. Matu-ritas 1994;20:91-9
19. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605-13 (Pubitemid 28502636)
20. Nelson H. Commonly used types of postmenopausal estrogens for treatment of hot fl ashes. JAMA 2004;291:1610-20 (Pubitemid 38552434)